Skip to content

Comparing Two Instrumentation Systems for the Treatment of Adolescent Scoliosis

Comparing the Moss Miami and Universal Spinal Instrumentation Systems for the Treatment of Adolescent Idiopathic Scoliosis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00273598
Enrollment
126
Registered
2006-01-09
Start date
1997-09-30
Completion date
2002-09-30
Last updated
2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Keywords

Scoliosis, spinal disease, pediatrics, Adolescents, Universal Spinal Instrumentation System, Moss Miami Spinal Instrumentation System, Orthopedic Surgery

Brief summary

Idiopathic scoliosis affects 2-5% of adolescents. This study will compare the quality of life, functional outcome, cosmetic result, and the correction of spinal deformity of two instrumentation systems for the treatment of adolescent idiopathic scoliosis.

Interventions

PROCEDUREMoss Miami Spine Instrumentation System
PROCEDUREUniversal Spine Instrumentation System

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Synthes Canada
CollaboratorINDUSTRY
DePuy-Acromed, Inc.
CollaboratorINDUSTRY
Johnson & Johnson
CollaboratorINDUSTRY
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 8-18 years * Diagnosis of idiopathic scoliosis requiring posterior instrumentation and fusion(including those also requiring anterior release with or without anterior instrumentation) who could receive either the USS or the Moss Miami system * Patients with scoliosis and an incidental finding of conus \< L1-2 disc level, provided they have no symptoms or signs * Patients with scoliosis and an incidental finding of a small syrinx (provided the syrinx is non-progressive and does not require neurosurgical treatment) * Patients with non-progressive spondylolysis

Exclusion criteria

* Spinal cord abnormalities with any neurologic symptoms or signs * Spinal cord lesions requiring neurosurgical interventions, such as hydromyelia requiring Arnold Chiari decompression * Primary muscle diseases, such as muscular dystrophy * Neurologic diseases (e.g. Charcot-Marie Tooth, Guillain-Barre syndrome, cerebral palsy, or spina bifida, etc.) * Primary abnormalities of bones(e.g. osteogenesis imperfecta) * Congenital scoliosis

Design outcomes

Primary

MeasureTime frame
- Quality of life at two years post-surgery, as measured by the self-report Quality of Life Profile for Spinal Disorders

Secondary

MeasureTime frame
Deformity, based on clinical exam and spinal radiographs
Clinicians' ratings of clinical photographs
Physical function
Surgeons' global satisfaction with the instrumentation system
Complications of treatment (infection, loss of fixation, neurologic damage, and non-union)
Surgical outcomes, as measured by blood transfusions, duration of surgery,and length of hospitalization

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026